Hybrid closed-loop systems are increasingly gaining recognition as a gold-standard option for diabetes management, and medtech makers are jumping at the opportunity to add their own artificial ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.

The National Institute for Health and Care Excellence (NICE), England’s cost-effectiveness watchdog, has finalized a draft guidance regarding hybrid closed-loop systems, concluding that the technology ...

A new clinical trial to investigate the use of artificial pancreas system is set to begin, bringing in touchscreen insulin pump maker Tandem Diabetes Care; Dexcom, which makes continuous glucose ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Data were derived from Ebekozien O, et al. OP 020.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of the CamAPS FX hybrid closed-loop system improved ...

Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.